( 0 1 0 1 O
Computed 1 9 1 9 O
Tomography 10 20 10 20 O
) 20 21 20 21 O
CT 22 24 22 24 O
scans 25 30 25 30 O
were 31 35 31 35 O
completed 36 45 36 45 O
within 46 52 46 52 O
4 53 54 53 54 B-upper_bound
weeks 55 60 55 60 I-upper_bound
prior 61 66 61 66 I-upper_bound
to 67 69 67 69 O
registration 70 82 70 82 O

Active 0 6 83 89 B-chronic_disease
autoimmune 7 17 90 100 I-chronic_disease
disorders 18 27 101 110 I-chronic_disease
or 28 30 111 113 O
conditions 31 41 114 124 B-chronic_disease
of 42 44 125 127 I-chronic_disease
immunosuppression 45 62 128 145 I-chronic_disease

Active 0 6 146 152 B-chronic_disease
infection 7 16 153 162 I-chronic_disease
requiring 17 26 163 172 O
treatment 27 36 173 182 O
with 37 41 183 187 O
antibiotics 42 53 188 199 B-treatment

Advanced 0 8 200 208 O
- 8 9 208 209 O
stage 9 14 209 214 O
( 15 16 215 216 O
i.e. 16 20 216 220 O
, 20 21 220 221 O
metastatic 22 32 222 232 B-cancer
) 32 33 232 233 O
Lung 34 38 234 238 B-cancer
Cancer 39 45 239 245 I-cancer
of 46 48 246 248 O
any 49 52 249 252 O
histologic 53 63 253 263 O
type 64 68 264 268 O

Age 0 3 269 272 B-age
18 4 6 273 275 B-lower_bound
years 7 12 276 281 I-lower_bound
and 13 16 282 285 O
older 17 22 286 291 O

Any 0 3 292 295 O
other 4 9 296 301 O
significant 10 21 302 313 O
medical 22 29 314 321 O
or 30 32 322 324 O
psychiatric 33 44 325 336 B-chronic_disease
conditions 45 55 337 347 I-chronic_disease
which 56 61 348 353 O
, 61 62 353 354 O
in 63 65 355 357 O
the 66 69 358 361 O
opinion 70 77 362 369 O
of 78 80 370 372 O
the 81 84 373 376 O
enrolling 85 94 377 386 O
investigator 95 107 387 399 O
, 107 108 399 400 O
may 109 112 401 404 O
interfere 113 122 405 414 O
with 123 127 415 419 O
consent 128 135 420 427 O
or 136 138 428 430 O
compliance 139 149 431 441 O
of 150 152 442 444 O
the 153 156 445 448 O
treatment 157 166 449 458 B-treatment
regimen 167 174 459 466 I-treatment

ECOG 0 4 467 471 B-clinical_variable
Performance 5 16 472 483 I-clinical_variable
Status 17 23 484 490 I-clinical_variable
0 24 25 491 492 B-lower_bound
to 26 28 493 495 O
2 29 30 496 497 B-upper_bound

Existing 0 8 498 506 O
autoimmune 9 19 507 517 B-chronic_disease
disorders 20 29 518 527 I-chronic_disease
or 30 32 528 530 O
conditions 33 43 531 541 O
of 44 46 542 544 O
immunosuppression 47 64 545 562 B-treatment
that 65 69 563 567 O
have 70 74 568 572 O
been 75 79 573 577 O
in 80 82 578 580 O
remission 83 92 581 590 O
for 93 96 591 594 O
less 97 101 595 599 O
than 102 106 600 604 O
6 107 108 605 606 B-upper_bound
months 109 115 607 613 I-upper_bound

Existing 0 8 614 622 O
diagnosis 9 18 623 632 O
or 19 21 633 635 O
evidence 22 30 636 644 O
of 31 33 645 647 O
organic 34 41 648 655 B-chronic_disease
brain 42 47 656 661 I-chronic_disease
syndrome 48 56 662 670 I-chronic_disease
that 57 61 671 675 O
might 62 67 676 681 O
preclude 68 76 682 690 O
participation 77 90 691 704 O
in 91 93 705 707 O
the 94 97 708 711 O
full 98 102 712 716 O
protocol 103 111 717 725 O

Existing 0 8 726 734 O
diagnosis 9 18 735 744 O
or 19 21 745 747 O
history 22 29 748 755 O
of 30 32 756 758 O
leptomeningeal 33 47 759 773 B-chronic_disease
disease 48 55 774 781 I-chronic_disease
, 55 56 781 782 O
spinal 57 63 783 789 B-chronic_disease
cord 64 68 790 794 I-chronic_disease
compression 69 80 795 806 I-chronic_disease
or 81 83 807 809 O
brain 84 89 810 815 B-cancer
metastases 90 100 816 826 I-cancer
unless 101 107 827 833 O

Existing 0 8 834 842 O
diagnosis 9 18 843 852 O
or 19 21 853 855 O
history 22 29 856 863 O
of 30 32 864 866 O
significant 33 44 867 878 O
impairment 45 55 879 889 B-chronic_disease
of 56 58 890 892 I-chronic_disease
basal 59 64 893 898 I-chronic_disease
cognitive 65 74 899 908 I-chronic_disease
function 75 83 909 917 I-chronic_disease
that 84 88 918 922 O
might 89 94 923 928 O
preclude 95 103 929 937 O
participation 104 117 938 951 O
in 118 120 952 954 O
the 121 124 955 958 O
full 125 129 959 963 O
protocol 130 138 964 972 O

Platelet 0 8 973 981 B-clinical_variable
count 9 14 982 987 I-clinical_variable
≥ 15 16 988 989 O
100,000 17 24 990 997 B-lower_bound
/ 24 25 997 998 I-lower_bound
mm3 25 28 998 1001 I-lower_bound
within 29 35 1002 1008 O
3 36 37 1009 1010 B-upper_bound
weeks 38 43 1011 1016 I-upper_bound
prior 44 49 1017 1022 I-upper_bound
to 50 52 1023 1025 O
registration 53 65 1026 1038 O

Replacement 0 11 1039 1050 O
doses 12 17 1051 1056 O
of 18 20 1057 1059 O
steroids 21 29 1060 1068 B-treatment
for 30 33 1069 1072 O
subjects 34 42 1073 1081 O
with 43 47 1082 1086 O
adrenal 48 55 1087 1094 B-chronic_disease
insufficiency 56 69 1095 1108 I-chronic_disease
are 70 73 1109 1112 O
allowed 74 81 1113 1120 O

Serum 0 5 1121 1126 B-clinical_variable
creatinine 6 16 1127 1137 I-clinical_variable
≤ 17 18 1138 1139 O
1.8 19 22 1140 1143 B-upper_bound
mg 23 25 1144 1146 I-upper_bound
/ 25 26 1146 1147 I-upper_bound
dL 26 28 1147 1149 I-upper_bound
obtained 29 37 1150 1158 O
within 38 44 1159 1165 O
3 45 46 1166 1167 B-upper_bound
weeks 47 52 1168 1173 I-upper_bound
prior 53 58 1174 1179 I-upper_bound
to 59 61 1180 1182 O
registration 62 74 1183 1195 O

Serum 0 5 1196 1201 B-clinical_variable
glutamic 6 14 1202 1210 I-clinical_variable
- 14 15 1210 1211 I-clinical_variable
oxaloacetic 15 26 1211 1222 I-clinical_variable
transaminase 27 39 1223 1235 I-clinical_variable
( 40 41 1236 1237 I-clinical_variable
SGOT 41 45 1237 1241 I-clinical_variable
) 45 46 1241 1242 I-clinical_variable
or 47 49 1243 1245 O
aspartate 50 59 1246 1255 B-clinical_variable
aminotransferase 60 76 1256 1272 I-clinical_variable
test 77 81 1273 1277 I-clinical_variable
( 82 83 1278 1279 I-clinical_variable
AST 83 86 1279 1282 I-clinical_variable
) 86 87 1282 1283 I-clinical_variable
≤ 88 89 1284 1285 O
2 90 91 1286 1287 B-upper_bound
x 92 93 1288 1289 I-upper_bound
institutional 94 107 1290 1303 I-upper_bound
upper 108 113 1304 1309 I-upper_bound
limit 114 119 1310 1315 I-upper_bound
( 120 121 1316 1317 I-upper_bound
IUL 121 124 1317 1320 I-upper_bound
) 124 125 1320 1321 I-upper_bound
of 126 128 1322 1324 O
normal 129 135 1325 1331 O
obtained 136 144 1332 1340 O
within 145 151 1341 1347 O
3 152 153 1348 1349 B-upper_bound
weeks 154 159 1350 1355 I-upper_bound
prior 160 165 1356 1361 I-upper_bound
to 166 168 1362 1364 O
registration 169 181 1365 1377 O

Serum 0 5 1378 1383 B-clinical_variable
glutamic 6 14 1384 1392 I-clinical_variable
- 14 15 1392 1393 I-clinical_variable
pyruvic 15 22 1393 1400 I-clinical_variable
transaminase 23 35 1401 1413 I-clinical_variable
( 36 37 1414 1415 I-clinical_variable
SGPT 37 41 1415 1419 I-clinical_variable
) 41 42 1419 1420 I-clinical_variable
or 43 45 1421 1423 O
alanine 46 53 1424 1431 B-clinical_variable
aminotransferase 54 70 1432 1448 I-clinical_variable
test 71 75 1449 1453 I-clinical_variable
( 76 77 1454 1455 I-clinical_variable
ALT 77 80 1455 1458 I-clinical_variable
) 80 81 1458 1459 I-clinical_variable
≤ 82 83 1460 1461 O
2 84 85 1462 1463 B-upper_bound
x 86 87 1464 1465 I-upper_bound
institutional 88 101 1466 1479 I-upper_bound
upper 102 107 1480 1485 I-upper_bound
limit 108 113 1486 1491 I-upper_bound
( 114 115 1492 1493 I-upper_bound
IUL 115 118 1493 1496 I-upper_bound
) 118 119 1496 1497 I-upper_bound
of 120 122 1498 1500 I-upper_bound
normal 123 129 1501 1507 I-upper_bound
obtained 130 138 1508 1516 O
within 139 145 1517 1523 O
3 146 147 1524 1525 B-upper_bound
weeks 148 153 1526 1531 I-upper_bound
prior 154 159 1532 1537 I-upper_bound
to 160 162 1538 1540 O
registration 163 175 1541 1553 O

Subject 0 7 1554 1561 O
has 8 11 1562 1565 O
other 12 17 1566 1571 O
malignancies 18 30 1572 1584 B-cancer
have 31 35 1585 1589 O
been 36 40 1590 1594 O
continuously 41 53 1595 1607 O
disease 54 61 1608 1615 O
free 62 66 1616 1620 O
for 67 70 1621 1624 O
≥ 71 72 1625 1626 O
5 73 74 1627 1628 B-lower_bound
years 75 80 1629 1634 I-lower_bound
prior 81 86 1635 1640 I-lower_bound
to 87 89 1641 1643 O
the 90 93 1644 1647 O
time 94 98 1648 1652 O
of 99 101 1653 1655 O
registration 102 114 1656 1668 O

Subjects 0 8 1669 1677 O
who 9 12 1678 1681 O
have 13 17 1682 1686 O
been 18 22 1687 1691 O
on 23 25 1692 1694 O
systemic 26 34 1695 1703 B-treatment
steroids 35 43 1704 1712 I-treatment
will 44 48 1713 1717 O
require 49 56 1718 1725 O
a 57 58 1726 1727 O
6 59 60 1728 1729 O
- 60 61 1729 1730 O
week 61 65 1730 1734 O
washout 66 73 1735 1742 O
period 74 80 1743 1749 O

Subjects 0 8 1750 1758 O
with 9 13 1759 1763 O
other 14 19 1764 1769 O
malignancies 20 32 1770 1782 B-cancer
are 33 36 1783 1786 O
eligible 37 45 1787 1795 O
if 46 48 1796 1798 O
they 49 53 1799 1803 O
have 54 58 1804 1808 O
been 59 63 1809 1813 O
continuously 64 76 1814 1826 O
disease 77 84 1827 1834 O
free 85 89 1835 1839 O
for 90 93 1840 1843 O
≥ 94 95 1844 1845 O
5 96 97 1846 1847 B-lower_bound
years 98 103 1848 1853 I-lower_bound
prior 104 109 1854 1859 I-lower_bound
to 110 112 1860 1862 O
the 113 116 1863 1866 O
time 117 121 1867 1871 O
of 122 124 1872 1874 O
registration 125 137 1875 1887 O

Subjects 0 8 1888 1896 O
with 9 13 1897 1901 O
prior 14 19 1902 1907 O
history 20 27 1908 1915 O
at 28 30 1916 1918 O
any 31 34 1919 1922 O
time 35 39 1923 1927 O
of 40 42 1928 1930 O
any 43 46 1931 1934 O
in 47 49 1935 1937 B-cancer
situ 50 54 1938 1942 I-cancer
cancer 55 61 1943 1949 I-cancer
, 61 62 1949 1950 O
including 63 72 1951 1960 O
lobular 73 80 1961 1968 B-cancer
carcinoma 81 90 1969 1978 I-cancer
of 91 93 1979 1981 I-cancer
the 94 97 1982 1985 I-cancer
breast 98 104 1986 1992 I-cancer
in 105 107 1993 1995 I-cancer
situ 108 112 1996 2000 I-cancer
, 112 113 2000 2001 O
cervical 114 122 2002 2010 O
cancer 123 129 2011 2017 O
in 130 132 2018 2020 O
situ 133 137 2021 2025 O
, 137 138 2025 2026 O
atypical 139 147 2027 2035 B-cancer
melanocytic 148 159 2036 2047 I-cancer
hyperplasia 160 171 2048 2059 I-cancer
or 172 174 2060 2062 O
Clark 175 180 2063 2068 B-cancer
I 181 182 2069 2070 I-cancer
melanoma 183 191 2071 2079 I-cancer
in 192 194 2080 2082 I-cancer
situ 195 199 2083 2087 I-cancer
or 200 202 2088 2090 O
basal 203 208 2091 2096 B-cancer
or 209 211 2097 2099 I-cancer
squamous 212 220 2100 2108 I-cancer
skin 221 225 2109 2113 I-cancer
cancer 226 232 2114 2120 I-cancer
are 233 236 2121 2124 O
eligible 237 245 2125 2133 O
, 245 246 2133 2134 O
provided 247 255 2135 2143 O
they 256 260 2144 2148 O
are 261 264 2149 2152 O
disease 265 272 2153 2160 O
- 272 273 2160 2161 O
free 273 277 2161 2165 O
at 278 280 2166 2168 O
the 281 284 2169 2172 O
time 285 289 2173 2177 O
of 290 292 2178 2180 O
registration 293 305 2181 2193 O

Treatment 0 9 2194 2203 B-treatment
with 10 14 2204 2208 I-treatment
corticosteroids 15 30 2209 2224 I-treatment
, 30 31 2224 2225 O
including 32 41 2226 2235 O
oral 42 46 2236 2240 B-treatment
steroids 47 55 2241 2249 I-treatment
( 56 57 2250 2251 O
i.e. 57 61 2251 2255 O
prednisone 62 72 2256 2266 B-treatment
, 72 73 2266 2267 O
dexamethasone 74 87 2268 2281 B-treatment
) 87 88 2281 2282 O
, 88 89 2282 2283 O
continuous 90 100 2284 2294 O
use 101 104 2295 2298 O
of 105 107 2299 2301 O
topical 108 115 2302 2309 B-treatment
steroid 116 123 2310 2317 I-treatment
creams 124 130 2318 2324 I-treatment
or 131 133 2325 2327 I-treatment
ointments 134 143 2328 2337 I-treatment
or 144 146 2338 2340 O
any 147 150 2341 2344 O
steroid 151 158 2345 2352 B-treatment
- 158 159 2352 2353 I-treatment
containing 159 169 2353 2363 I-treatment
inhalers 170 178 2364 2372 I-treatment

White 0 5 2373 2378 B-clinical_variable
blood 6 11 2379 2384 I-clinical_variable
cell 12 16 2385 2389 I-clinical_variable
( 17 18 2390 2391 I-clinical_variable
WBC 18 21 2391 2394 I-clinical_variable
) 21 22 2394 2395 I-clinical_variable
count 23 28 2396 2401 I-clinical_variable
≥ 29 30 2402 2403 O
3,000 31 36 2404 2409 B-lower_bound
/ 36 37 2409 2410 I-lower_bound
mm3 37 40 2410 2413 I-lower_bound
within 41 47 2414 2420 O
3 48 49 2421 2422 B-upper_bound
weeks 50 55 2423 2428 I-upper_bound
prior 56 61 2429 2434 I-upper_bound
to 62 64 2435 2437 O
registration 65 77 2438 2450 O

metastases 0 10 2451 2461 B-cancer
have 11 15 2462 2466 O
been 16 20 2467 2471 O
locally 21 28 2472 2479 O
treated 29 36 2480 2487 O
and 37 40 2488 2491 O
have 41 45 2492 2496 O
remained 46 54 2497 2505 O
clinically 55 65 2506 2516 O
controlled 66 76 2517 2527 O
and 77 80 2528 2531 O
asymptomatic 81 93 2532 2544 O
for 94 97 2545 2548 O
at 98 100 2549 2551 O
least 101 106 2552 2557 O
14 107 109 2558 2560 B-lower_bound
days 110 114 2561 2565 I-lower_bound
following 115 124 2566 2575 O
treatment 125 134 2576 2585 B-treatment

subject 0 7 2586 2593 O
has 8 11 2594 2597 O
no 12 14 2598 2600 O
residual 15 23 2601 2609 B-chronic_disease
neurological 24 36 2610 2622 I-chronic_disease
dysfunction 37 48 2623 2634 I-chronic_disease
and 49 52 2635 2638 O
has 53 56 2639 2642 O
been 57 61 2643 2647 O
off 62 65 2648 2651 O
corticosteroids 66 81 2652 2667 B-treatment
for 82 85 2668 2671 O
at 86 88 2672 2674 O
least 89 94 2675 2680 O
14 95 97 2681 2683 B-lower_bound
days 98 102 2684 2688 I-lower_bound
prior 103 108 2689 2694 I-lower_bound
to 109 111 2695 2697 O
registration 112 124 2698 2710 O

